This protocol is judged by an institutional evaluate board, an unbiased group that assessments any medical trials involving human beings. If a research involves a Plan I drug, when the board approves the protocol as ethical, the scientists should apply for an investigational new drug (IND) variety within the FDA.Even though the protocols needed to